Annually on November 10th, NET Cancer Day, the world NET (neuroendocrine tumor) community joins together to raise awareness about cancers called neuroendocrine tumors and the need for timely detection and diagnosis. More than 50% of all NET patients are incorrectly diagnosed and initially treated for the wrong disease. Misdiagnoses or delayed diagnoses mean that NET patients are treated on average five years for the wrong disease; often the correct diagnosis is not made until the disease has spread (metastasized).

Read more about NET Cancer Day.

Read more about the First Global NET Patient Survey, a collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis Pharmaceuticals.